Kelly Kao

920 total citations
17 papers, 526 citations indexed

About

Kelly Kao is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Kelly Kao has authored 17 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 6 papers in Pediatrics, Perinatology and Child Health and 3 papers in Pharmacology. Recurrent topics in Kelly Kao's work include Pregnancy and Medication Impact (8 papers), Maternal Mental Health During Pregnancy and Postpartum (7 papers) and Prenatal Substance Exposure Effects (3 papers). Kelly Kao is often cited by papers focused on Pregnancy and Medication Impact (8 papers), Maternal Mental Health During Pregnancy and Postpartum (7 papers) and Prenatal Substance Exposure Effects (3 papers). Kelly Kao collaborates with scholars based in United States, Canada and Russia. Kelly Kao's co-authors include Christina Chambers, Kenneth Lyons Jones, Diana Johnson, Haruna S. Feldman, Hillary Klonoff‐Cohen, Suzanne Lindsay, Smriti Rao, Donald J. Slymen, Mark J. Roth and Anick Bérard and has published in prestigious journals such as Psychological Assessment, Alcoholism Clinical and Experimental Research and Frontiers in Pharmacology.

In The Last Decade

Kelly Kao

17 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Kao United States 11 205 189 135 89 61 17 526
Jackie Finik United States 16 182 0.9× 237 1.3× 149 1.1× 106 1.2× 44 0.7× 36 625
Violetta Skrzypulec Poland 18 248 1.2× 201 1.1× 38 0.3× 81 0.9× 30 0.5× 42 887
Sachiko Baba Japan 12 147 0.7× 131 0.7× 96 0.7× 54 0.6× 62 1.0× 30 511
John M. Feller Australia 11 196 1.0× 390 2.1× 53 0.4× 41 0.5× 50 0.8× 16 602
Sneha Sridhar United States 16 204 1.0× 362 1.9× 633 4.7× 49 0.6× 102 1.7× 31 948
Emily Johnson United States 9 108 0.5× 275 1.5× 130 1.0× 113 1.3× 81 1.3× 18 674
Shannon L. Gillespie United States 16 235 1.1× 198 1.0× 160 1.2× 110 1.2× 90 1.5× 41 650
Martina Rauchfuß Germany 17 352 1.7× 108 0.6× 299 2.2× 165 1.9× 23 0.4× 51 872
Azadeh Tavoli Iran 10 193 0.9× 90 0.5× 32 0.2× 139 1.6× 22 0.4× 29 590
Baizhuang Xu Finland 11 119 0.6× 217 1.1× 99 0.7× 22 0.2× 71 1.2× 13 518

Countries citing papers authored by Kelly Kao

Since Specialization
Citations

This map shows the geographic impact of Kelly Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Kao more than expected).

Fields of papers citing papers by Kelly Kao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Kao. The network helps show where Kelly Kao may publish in the future.

Co-authorship network of co-authors of Kelly Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Kao. A scholar is included among the top collaborators of Kelly Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Kao. Kelly Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bérard, Anick, Odile Sheehy, Jin‐Ping Zhao, et al.. (2019). Impact of antidepressant use, discontinuation, and dosage modification on maternal depression during pregnancy. European Neuropsychopharmacology. 29(7). 803–812. 12 indexed citations
2.
Chambers, Christina, Richard F. Clark, Robert H. Felix, et al.. (2018). Interprofessional Education: Addressing Competencies for Exposures in Pregnancy. Reproductive Toxicology. 80. 163–163. 1 indexed citations
3.
Bérard, Anick, Andrea Gaedigk, Odile Sheehy, et al.. (2017). Association between CYP2D6 Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during Pregnancy. Frontiers in Pharmacology. 8. 18 indexed citations
4.
Zagorodnikova, Ksenia, Kelly Kao, Diana Johnson, Kenneth Lyons Jones, & Christina Chambers. (2017). Prenatal metronidazole use and adverse pregnancy outcomes in a disease-controlled population. Reproductive Toxicology. 72. 220–221. 1 indexed citations
5.
Sheehy, Odile, Christina Chambers, William D. Fraser, et al.. (2016). Impact of maternal prenatal and parental postnatal stress on 1-year-old child development: results from the OTIS antidepressants in pregnancy study. Archives of Women s Mental Health. 19(5). 835–843. 33 indexed citations
6.
RamachandraRao, Satish, Linda Awdishu, Rachael Overcash, et al.. (2016). Proteomic analyses of Urine Exosomes reveal New Biomarkers of Diabetes in Pregnancy. PubMed. 1(1). 11–22. 21 indexed citations
7.
Sheehy, Odile, Christina Chambers, William D. Fraser, et al.. (2015). The ASQ and R-PDQ telephone-administered validation within the OTIS antidepressant in pregnancy study.. Psychological Assessment. 27(4). 1507–1512. 2 indexed citations
8.
Mody, Sheila K., et al.. (2015). Using the electronic medical record to refer women taking category D or X medications for teratogen and contraceptive counseling. Birth Defects Research Part A Clinical and Molecular Teratology. 103(7). 644–647. 6 indexed citations
9.
Bérard, Anick, Odile Sheehy, Christina Chambers, et al.. (2012). Reliability and validity of the 4‐item perceived stress scale among pregnant women: Results from the OTIS antidepressants study. Research in Nursing & Health. 35(4). 363–375. 141 indexed citations
10.
Feldman, Haruna S., Kenneth Lyons Jones, Suzanne Lindsay, et al.. (2012). Prenatal Alcohol Exposure Patterns and Alcohol‐Related Birth Defects and Growth Deficiencies: A Prospective Study. Alcoholism Clinical and Experimental Research. 36(4). 670–676. 110 indexed citations
11.
Gorman, Jessica R., Kelly Kao, & Christina Chambers. (2012). Breastfeeding among Women Exposed to Antidepressants during Pregnancy. Journal of Human Lactation. 28(2). 181–188. 30 indexed citations
12.
Feldman, Haruna S., Kenneth Lyons Jones, Suzanne Lindsay, et al.. (2011). Patterns of prenatal alcohol exposure and associated non‐characteristic minor structural malformations: A prospective study. American Journal of Medical Genetics Part A. 155(12). 2949–2955. 9 indexed citations
13.
Chitayat, David, Kelly Kao, Facundo García‐Bournissen, et al.. (2010). Prenatal Exposure to Mycophenolate Mofetil: An Updated Estimate. Journal of Obstetrics and Gynaecology Canada. 32(8). 794–797. 46 indexed citations
14.
Chen, Brian H., et al.. (2006). Prevalence of periconceptional folic acid use and perceived barriers to the postgestation continuance of supplemental folic acid: Survey results from a Teratogen Information Service. Birth Defects Research Part A Clinical and Molecular Teratology. 76(3). 193–199. 31 indexed citations
15.
Kao, Kelly, Kenneth Lyons Jones, Lyn M. Dick, et al.. (2005). Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. American Journal of Medical Genetics Part A. 136A(2). 117–121. 49 indexed citations
16.
Jones, Kenneth Lyons, Kathleen A. Johnson, Lyn M. Dick, et al.. (2002). Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine. Teratology. 65(3). 125–130. 15 indexed citations
17.
Jones, Kenneth Lyons, Kathleen A. Johnson, Lyn M. Dick, et al.. (2002). Pregnancy Outcomes After First Trimester Exposure to Phentermine/Fenfluramine. Obstetrical & Gynecological Survey. 57(9). 548–549. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026